Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Tikcro
Raanana, Israel
B
1-10 Employees
1999
Key takeaway
The company utilizes a unique 3D antigen immunization technology to develop innovative therapeutic antibodies for cancer immunotherapy, which enhances their blocking functionality and therapeutic window. This approach addresses key limitations of existing antibody drugs, aiming to improve clinical efficacy while reducing treatment-related toxicities.
Reference
Product
3D Antigen DesignTikcro | Tikcro
Immunovative Therapies Ltd.
Jerusalem, Israel
B
11-50 Employees
2004
Key takeaway
Mirror Biologics, Inc. specializes in developing innovative immunotherapy products, including their lead product, AlloStim®, which utilizes their proprietary Mirror Effect® technology to enhance the immune response against cancer. This next-generation approach not only broadens the applicability of immunotherapy but also aims to reduce costs and side effects, making it a significant advancement in cancer treatment.
Reference
Core business
Vaccines | Mirrorbio
Mirror Biologics, Inc. (“MBI”) is an international biopharmaceutical company specialized in development and manufacturing of next generation immunotherapy products where the active ingredients are living immune cells. www.mirrorbio.com
Biond Biologics
Misgav Regional Council, Israel
B
11-50 Employees
2016
Key takeaway
Biond Biologics focuses on developing immuno-oncology products that target innovative biological pathways in tumor immunology.
Reference
Core business
About Biond Biologics – Biond Biologics
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
IBI-Ag
Ness Ziona, Israel
B
1-10 Employees
2017
Key takeaway
IBI-Ag specializes in developing innovative single domain antibody bioinsecticides that enhance crop production while minimizing harm to health and the environment. Their IBI-Ag technology offers tailored biological pest control solutions, emphasizing sustainability and efficiency in agricultural practices.
Reference
Core business
IBI-Ag – Innovative Bioinsecticides
Kitov Pharmaceuticals
Tel-Aviv, Israel
B
1-10 Employees
2010
Key takeaway
The company, Purple Biotech, is focused on developing first-in-class therapies to combat cancer, including IM1240, a conditionally-activated tri-specific antibody that engages T cells and NK cells, highlighting their innovative approach to addressing immune evasion and drug resistance in cancer treatment.
Reference
Core business
Purple Biotech first-in-class therapies to overcome tumor immune evasion and drug resistance
Purple BioTech - are committed to providing cancer patients with first-in-class, effective, and durable therapies by overcoming tumor immune evasion and drug resistance.
ADVA Biotechnologies
Haifa, Israel
B
11-50 Employees
2016
Key takeaway
Adva Biotechnology is focused on revolutionizing cell therapy manufacturing processes, which may be relevant in the context of developing advanced therapies like bispecific antibodies. Their innovative ADVA platform employs unique technology to enhance autologous cell therapy.
Reference
Core business
Home // AdvaBio
VALUING LIFE Granting Advanced Therapies to Patients Automated Autologous Cell Manufacturing Platform Adva Biotechnology introduces the ADVA platform, a fully controlled, flexible, and automated cell processing platform. The system provides a solution to autologous cell therapy manufacturing processes using the unique CAMP (Continues Adaptive Multi-Parameter) technology.
Tarom Applied Technologies
Drom HaSharon Regional Council, Israel
B
11-50 Employees
1989
Key takeaway
The company, Tarom, emphasizes its commitment to meeting customer needs with high-quality technologies and products. Additionally, Celsee Diagnostics specializes in innovative liquid biopsy products, including a fully automated system for detecting circulating tumor cells, which is relevant to the development of targeted therapies like bispecific antibodies.
Reference
Product
immucor - Tarom Applied technologies
SBI Japan-Israel Innovation Fund
Herzliya, Israel
B
- Employees
2017
Key takeaway
The company is focused on innovative technologies and therapies, particularly in the field of gene therapy and gene editing for rare diseases.
Reference
Core business
Home | SBIJI
EdiTy Therapeutics
Ness Ziona, Israel
B
1-10 Employees
2020
Key takeaway
Edity Therapeutics is pioneering a platform that utilizes immune cells to deliver therapeutic proteins directly to the cytoplasm of diseased cells, which could significantly enhance treatment strategies for various conditions, including oncology and genetic diseases. Their innovative approach to cellular reprogramming has the potential to transform therapeutic paradigms by targeting disease at the intracellular level.
Reference
Core business
Home - Edity Therapeutics
Edity Therapeutics - Cellular Re-programming utilizing the Immune system: We use immune cells to deliver protein directly to the cytoplasm of diseased cells to improve patient health and longevity.
Entera Bio
Jerusalem, Israel
B
11-50 Employees
2010
Key takeaway
The company, Santora, is focused on addressing high unmet clinical needs through the development of innovative oral protein and peptide replacement therapies. Their approach aims to improve treatment outcomes for patients managing chronic diseases, potentially aligning with advancements in therapeutic modalities like bispecific antibodies.
Reference
Core business
Home - EnteraBio
We are a clinical stage, global company, focused on high unmet clinical needs where oral delivery of a protein therapy can significantly improve the standard of care. We are developing first-in-class, daily tablet protein and peptide replacement therapies, designed for patients to live healthier and injection-free, as they manage their chronic diseases. Our goal is for our small, oral protein tablets to change treatment outcomes for patients globally.
Technologies which have been searched by others and may be interesting for you:
The bispecific antibody industry in Israel is a rapidly evolving sector with several key considerations for potential investors or researchers. Israel is recognized for its advanced biotechnology ecosystem, driven by a robust pool of scientific talent and innovative startups. Regulatory frameworks are essential, as compliance with local and international guidelines, such as those from the FDA and EMA, is crucial for product development and market entry. Challenges include navigating the complexities of clinical trials and ensuring consistent manufacturing processes, as these antibodies often require sophisticated techniques. The competitive landscape is marked by both established companies and emerging biotechs, making collaboration and partnerships vital for success. Opportunities for growth are significant, particularly in therapeutic areas like oncology and autoimmune diseases, where bispecific antibodies show promise in enhancing treatment efficacy. Global market relevance is heightened as Israeli firms often target international markets, leveraging strategic alliances to scale their innovations. Environmental concerns also play a role, as companies increasingly focus on sustainable practices in research and production. As the industry matures, staying informed about technological advancements, regulatory changes, and market dynamics will be essential for anyone looking to engage with the bispecific antibody sector in Israel.
Some interesting numbers and facts about your company results for Bispecific Antibody
| Country with most fitting companies | Israel |
| Amount of fitting manufacturers | 128 |
| Amount of suitable service providers | 44 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1989 |
| Youngest suiting company | 2020 |
Some interesting questions that has been asked about the results you have just received for Bispecific Antibody
What are related technologies to Bispecific Antibody?
Based on our calculations related technologies to Bispecific Antibody are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Bispecific Antibody?
The most represented industries which are working in Bispecific Antibody are Other, Biotechnology, Medical, Pharmaceuticals, IT, Software and Services
How does ensun find these Bispecific Antibody Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.